Suchergebnisse - "Jordan B King"

PubPharm (14)

1

Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2024

von Joshua A. Jacobs | Catherine G. Derington | Alexander R. Zheutlin | +8

2

Effectiveness of Hypertension Management Strategies in SPRINT‐Eligible US Adults: A Simulation Study

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2024

von Fengdi Zhang | Kelsey B. Bryant | Andrew E. Moran | +10

3

Glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor use among adults with diabetes mellitus by cardiovascular-kidney disease risk: National Health and Nutrition Examination Surveys, 2015–2020

in: American Journal of Preventive Cardiology | 2024

von Joshua A. Jacobs | Alexander R. Zheutlin | Catherine G. Derington | +3

4

Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2021

von Brandon K. Bellows | Yiyi Zhang | Zugui Zhang | +14

5

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

in: PLoS ONE | 2021

von Catherine G Derington | Jordana B Cohen | April F Mohanty | +27

6

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2021

von April F. Mohanty | Emily B. Levitan | Jordan B. King | +12

7

Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2021

von Catherine G. Derington | Lisandro D. Colantonio | Jennifer S. Herrick | +12

8

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.

in: PLoS ONE | 2020

von Catherine G Derington | Jordan B King | Thomas Delate | +4

9

Impact of Self‐Monitoring of Blood Pressure on Processes of Hypertension Care and Long‐Term Blood Pressure Control

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2020

von Kelsey B. Bryant | James P. Sheppard | Natalia Ruiz‐Negrón | +8

10

PCSK9 Inhibitor Use in the Real World: Data From the National Patient‐Centered Research Network

in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2019

von Alanna M. Chamberlain | Yan Gong | Kathryn McAuliffe Shaw | +14